Viewing Study NCT05882734


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 11:14 PM
Study NCT ID: NCT05882734
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2023-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
Sponsor: EMD Serono Research & Development Institute, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module